Using a Question Prompt List As a Communication Aid in Advanced Cancer Care
Overview
Affiliations
Purpose: Oncologists and patients often avoid discussing prognosis, treatment failure, and end-of-life planning. Thus, many patients still overestimate their prognosis and possibility of cure, impairing decision making. We piloted a question prompt list (QPL) covering these issues to determine whether it would affect patient anxiety and how it would be used and received by new oncology patients.
Materials And Methods: A one-page checklist of common questions surrounding cancer care, quality of life, and end of life was created from previous instruments. A total of 30 patients with advanced or metastatic head and neck cancer were recruited from outpatient clinics. Patients received the QPL before their initial consultation. Patient anxiety, satisfaction, and information/decision-making preferences were assessed using validated instruments. Patient opinions regarding the QPL were solicited through Likert-scale items.
Results: During their visit, 27 patients (90%) used the QPL, but notably, none shared it directly with their oncologist. Most participants felt that the QPL was relevant and helpful (90%) and recommended that more physicians use this sort of list (90%) while disagreeing that the QPL made them feel anxious (80%). Generally, participants were highly satisfied with the consultation, and their anxiety decreased during the visit (P < .005).
Conclusion: A simple, one-page QPL addressing cancer treatment, prognosis, quality of life, and end-of-life issues was well received by new oncology patients and did not affect patient anxiety or physician workflow. Follow-up studies will determine whether use of the QPL increases knowledge, facilitates decision making, and improves advance-care planning.
Development of a generic decision guide for patients in oncology: a qualitative interview study.
Schilling L, Kaden J, Ban I, Berger-Hoger B BMC Med Inform Decis Mak. 2025; 25(1):125.
PMID: 40065302 PMC: 11895154. DOI: 10.1186/s12911-025-02960-6.
Young-onset metastatic colorectal cancer: an opportunity and a vision for progress in cancer.
Cooray P, Cooper N Med Oncol. 2025; 42(4):95.
PMID: 40056288 PMC: 11890396. DOI: 10.1007/s12032-025-02640-5.
Baral A, Diggs B, Aka A, Williams R, Ortega N, Marrakchi El Fellah R J Cancer Educ. 2024; .
PMID: 39294413 DOI: 10.1007/s13187-024-02507-9.
Rault A, Dolbeault S, Terrasson J, Bouleuc C, Cottu P, Piperno-Neumann S Pilot Feasibility Stud. 2024; 10(1):116.
PMID: 39198868 PMC: 11351337. DOI: 10.1186/s40814-024-01543-y.
Saeed F, Dahl S, Horowitz R, Duberstein P, Epstein R, Fiscella K Kidney Med. 2023; 5(7):100671.
PMID: 37492114 PMC: 10363565. DOI: 10.1016/j.xkme.2023.100671.